Mode
Text Size
Log in / Sign up

Congenital Heart Defects

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Congenital Heart Defects

6 trials tracked for Congenital Heart Defects: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 9 citations.

6Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 1 Other / NA 4
  1. Phase 3 Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass Completed · 9 cited
  2. Phase 2 Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease? Completed
  3. N/A Use of Color Doppler in Routine Examination of Fetal Heart in Second Trimester Completed
  4. N/A Assessing the Hemodynamic Benefits of Cardiac Resynchronization Therapy in Children Following Open-Heart Surgery Completed
  5. N/A Congenital Heart Adolescents: Program of Transition Evaluation Research Completed
  6. N/A Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.